Patents by Inventor Jingwei Li

Jingwei Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11556761
    Abstract: A method for compressing a neural network model includes: obtaining a first trained teacher model and a second trained teacher model based on N training samples, N being a positive integer greater than 1; for each of the N training samples, determining a first guide component of the first teacher model and a second guide component of the second teacher model respectively, determining a sub optimization target corresponding to the training sample and configured to optimize a student model according to the first guide component and the second guide component, and determining a joint optimization target based on each of the N training samples and a sub optimization target corresponding to the training sample; and training the student model based on the joint optimization target.
    Type: Grant
    Filed: March 24, 2020
    Date of Patent: January 17, 2023
    Assignee: Beijing Xiaomi Intelligent Technology Co., Ltd.
    Inventors: Xiang Li, Yuhui Sun, Jingwei Li, Jialiang Jiang
  • Publication number: 20230002376
    Abstract: The present application provides bicyclic amines of Formula (I): or a pharmaceutically acceptable salt thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
    Type: Application
    Filed: June 21, 2022
    Publication date: January 5, 2023
    Inventors: Joshua Hummel, Jingwei Li, Ding-Quan Qian, Liangxing Wu
  • Patent number: 11507888
    Abstract: A training method for a machine translation model, includes: obtaining a multi-domain mixed training data set; performing data domain classification on a plurality of training data pairs in the training data set to obtain at least two domain data subsets; based on each domain data subset, determining at least two candidate optimization targets for the domain data subset, and training at least two candidate single domain models corresponding to each domain data subset based on the at least two candidate optimization targets, respectively; testing the at least two candidate single domain models corresponding to each domain data subset separately, and selecting a candidate optimization target with a highest test accuracy as a designated optimization target for the domain data subset; and training a hybrid domain model based on each domain data subset in the training data set and the designated optimization target corresponding to each domain data subset.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: November 22, 2022
    Assignee: Beijing Xiaomi Intelligent Technology Co., Ltd.
    Inventors: Yuhui Sun, Xiang Li, Jingwei Li
  • Publication number: 20220340600
    Abstract: The present disclosure is directed to compounds of Formula (I): which modulate PD-1/PD-L1 protein/protein interaction, compositions, and methods of treating various diseases, including infectious diseases and cancer.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 27, 2022
    Inventors: Jingwei Li, Liangxing Wu, Wenqing Yao
  • Patent number: 11472791
    Abstract: The present application provides pyrazolyl pyrimidinylamine inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
    Type: Grant
    Filed: March 4, 2020
    Date of Patent: October 18, 2022
    Assignee: Incyte Corporation
    Inventors: Joshua Hummel, Jingwei Li, Zhenwu Li, Ding-Quan Qian, Liangxing Wu, Kaijiong Xiao, Meizhong Xu, Jeffrey C. Yang, Wenqing Yao, Fenglei Zhang, Min Ye, Yingnan Chen, Margaret Favata, Yvonne Lo
  • Patent number: 11436419
    Abstract: A bilingual corpora screening method includes: acquiring multiple pairs of bilingual corpora, wherein each pair of the bilingual corpora comprises a source corpus and a target corpus; training a machine translation model based on the multiple pairs of bilingual corpora; obtaining a first feature of each pair of bilingual corpora based on the trained machine translation model; training a language model based on the multiple pairs of bilingual corpora; obtaining feature vectors of each pair of bilingual corpora and determining a second feature of each pair of bilingual corpora based on the trained language model; determining a quality value of each pair of bilingual corpora according to the first feature and the second feature of each pair of bilingual corpora; and screening each pair of bilingual corpora according to the quality value of each pair of bilingual corpora.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: September 6, 2022
    Assignee: Beijing Xiaomi Mobile Software Co., Ltd.
    Inventors: Jingwei Li, Yuhui Sun, Xiang Li
  • Patent number: 11427567
    Abstract: The present application provides imidazolyl pyrimidinylamine inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: August 30, 2022
    Assignee: Incyte Corporation
    Inventors: Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Liangxing Wu, Wenqing Yao, Min Ye, Yingnan Chen, Margaret Favata, Yvonne Lo
  • Patent number: 11407749
    Abstract: Disclosed are compounds of Formula (I?), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: August 9, 2022
    Assignee: Incyte Corporation
    Inventors: Liangxing Wu, Bo Shen, Jingwei Li, Zhenwu Li, Kai Liu, Fenglei Zhang, Wenqing Yao
  • Patent number: 11401279
    Abstract: The present disclosure is directed to compounds of Formula (I): which modulate PD-1/PD-L1 protein/protein interaction, compositions, and methods of treating various diseases, including infectious diseases and cancer.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: August 2, 2022
    Assignee: Incyte Corporation
    Inventors: Jingwei Li, Liangxing Wu, Wenqing Yao
  • Patent number: 11396478
    Abstract: A method and system for producing low-alkalinity sulphoaluminate cement with a new mineral system using steel slag. The method includes the following steps: evenly mixing and homogenizing ground steel slag with dry desulfurization gypsum, aluminum ash and carbide slag according to a set ratio; and conveying the homogenized raw meal to a rotary kiln for calcination to obtain cement clinker, where the calcination temperature is 1200° C.-1270° C., and the calcination time is 20-60 min; the alkalinity modulus of the homogenized cement raw meal is 0.81-0.9, and the Fe2O3 content is 8-13%. The method breaks through the requirements on contents of calcium, aluminum and iron in traditional sulphoaluminate cement production, and realizes application of a large amount of steel slag.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: July 26, 2022
    Assignee: SHANDONG UNIVERSITY
    Inventors: Xujiang Wang, Wenlong Wang, Jingwei Li, Yanpeng Mao, Chao Zhang, Changliang Wu
  • Patent number: 11392779
    Abstract: A bilingual corpora screening method includes: acquiring multiple pairs of bilingual corpora, wherein each pair of the bilingual corpora comprises a source corpus and a target corpus; training a machine translation model based on the multiple pairs of bilingual corpora; obtaining a first feature of each pair of bilingual corpora based on the trained machine translation model; training a language model based on the multiple pairs of bilingual corpora; obtaining feature vectors of each pair of bilingual corpora and determining a second feature of each pair of bilingual corpora based on the trained language model; determining a quality value of each pair of bilingual corpora according to the first feature and the second feature of each pair of bilingual corpora; and screening each pair of bilingual corpora according to the quality value of each pair of bilingual corpora.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: July 19, 2022
    Assignee: Beijing Xiaomi Mobile Software Co., Ltd.
    Inventors: Jingwei Li, Yuhui Sun, Xiang Li
  • Publication number: 20220214448
    Abstract: A point cloud data fusion method includes: point cloud data collected respectively by a primary radar and each secondary radar arranged on a target vehicle is acquired, where the primary radar is one of radars on the target vehicle, and the secondary radar is a radar other than the primary radar among the radars on the target vehicle; a reflectivity in the point cloud data collected by the secondary radar is adjusted based on a pre-determined reflectivity calibration table of the secondary radar to obtain adjusted point cloud data of the secondary radar, where the reflectivity calibration table represents target reflectivity information of the primary radar, which matches each reflectivity corresponding to each scanning line of the secondary radar; and the point cloud data collected by the primary radar and the adjusted point cloud data corresponding to the secondary radar are fused to obtain fused point cloud data.
    Type: Application
    Filed: March 2, 2022
    Publication date: July 7, 2022
    Applicant: SHANGHAI SENSETIME INTELLIGENT TECHNOLOGY CO., LTD.
    Inventors: Jingwei LI, Zhe WANG
  • Publication number: 20220194931
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 23, 2022
    Inventors: Liangxing Wu, Jingwei Li, Chao Qi, Fenglei Zhang, Zhenwu Li, Wenyu Zhu, Zhiyong Yu, Kaijiong Xiao, Liang Lu, Song Mei, Ding-Quan Qian, Chunhong He, Yingda Ye, Meizhong Xu, Wenqing Yao
  • Patent number: 11339149
    Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: May 24, 2022
    Assignee: Incyte Corporation
    Inventors: Liangxing Wu, Jingwei Li, Wenqing Yao, Chao Qi, Ding-Quan Qian, Fenglei Zhang
  • Publication number: 20220113403
    Abstract: Point cloud data collected by a radar device on a target vehicle can be acquired. Information on an obstacle within a set range from the target vehicle is determined based on the point cloud data. Radar blind zone information of the target vehicle is determined based on beam information of a beam transmitted by the radar device, as well as the information on the obstacle determined. The target vehicle is controlled according to the radar blind zone information of the target vehicle.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 14, 2022
    Applicant: SHANGHAI SENSETIME INTELLIGENT TECHNOLOGY CO., LTD.
    Inventors: Jingwei LI, Zhe WANG
  • Patent number: 11283172
    Abstract: The present invention relates to an integration module system of millimeter-wave and non-millimeter-wave antennas and an electronic apparatus, the system comprising a millimeter-wave antenna module and a non-millimeter-wave environment, the millimeter-wave antenna module forming a communication connection with the non-millimeter-wave environment for realizing reusing of the millimeter-wave antenna module to achieve a function of non-millimeter-wave antenna(s). The present invention proposes directly reusing a millimeter-wave antenna module, which is designed so that this module also has an antenna function of a non-millimeter-wave module, while an individual module's own volume does not need to be increased, and the module itself does not need to have additionally-added antenna traces, that is, with the same volume, a function of non-millimeter-wave antenna(s) may be further added.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: March 22, 2022
    Inventors: Huan-Chu Huang, Jiaguo Lu, Hong Lin, Junyong Liu, Zhixing Qi, Minhui Zeng, Yanchao Zhou, Jingwei Li, Tao Ma
  • Patent number: 11220513
    Abstract: The present invention provides unified synthesis of the C1-C19 building blocks of halichondrins and analogs thereof using selective coupling of poly-halogenated nucleophiles in chromium-mediated coupling reactions. The present invention also provides a practical and efficient synthesis of C20-C38 building blocks of halichondrins and analogs thereof. Also provided herein are general methods of selective activation and coupling of poly-halogenated analogs with an aldehyde. The provided coupling reactions are selective for halo-enone and halo-acetylenic ketal over vinyl halide and halide attached to a sp hybridized carbon. The provided efficient selective coupling reactions can allow easy access to the C1-C19 building blocks and C20-C38 building blocks of halichondrins and analogs thereof with limited or no purification or separation of the intermediates.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: January 11, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: Yoshito Kishi, Wuming Yan, Jingwei Li, Zhanjie Li, Kenzo Yahata
  • Publication number: 20210380584
    Abstract: Disclosed are compounds of Formula (I?), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: August 18, 2021
    Publication date: December 9, 2021
    Inventors: Liangxing Wu, Jingwei Li, Wenqing Yao
  • Publication number: 20210347771
    Abstract: Disclosed are compounds of Formula (I?), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
    Type: Application
    Filed: December 11, 2020
    Publication date: November 11, 2021
    Inventors: Liangxing Wu, Bo Shen, Jingwei Li, Zhenwu Li, Kai Liu, Fenglei Zhang, Wenqing Yao
  • Publication number: 20210344115
    Abstract: The present invention relates to an integration module system of millimeter-wave and non-millimeter-wave antennas and an electronic apparatus, the system comprising a millimeter-wave antenna module and a non-millimeter-wave environment, the millimeter-wave antenna module forming a communication connection with the non-millimeter-wave environment for realizing reusing of the millimeter-wave antenna module to achieve a function of non-millimeter-wave antenna(s). The present invention proposes directly reusing a millimeter-wave antenna module, which is designed so that this module also has an antenna function of a non-millimeter-wave module, while an individual module's own volume does not need to be increased, and the module itself does not need to have additionally-added antenna traces, that is, with the same volume, a function of non-millimeter-wave antenna(s) may be further added.
    Type: Application
    Filed: June 30, 2020
    Publication date: November 4, 2021
    Applicants: ETHETA COMMUNICATION TECHNOLOGY (SHENZHEN) CO.,LTD, EAST CHINA RESEARCH INSTITUTE OF MICROELECTRONICS
    Inventors: Huan-Chu HUANG, Jiaguo LU, Hong LIN, Junyong LIU, Zhixing QI, Minhui ZENG, Yanchao ZHOU, Jingwei LI, Tao MA